Medifast (NYSE:MED) Issues Q2 2024 Earnings Guidance
Medifast (NYSE:MED – Get Free Report) issued an update on its second quarter 2024 earnings guidance on Monday morning. The company provided EPS guidance of 0.050-0.400 for the period, compared to the consensus EPS estimate of 0.780. The company issued revenue guidance of $150.0 million-$170.0 million, compared to the consensus revenue estimate of $168.9 million. […]